Crossmark

Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 ‘shared epitope’ are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis

Crossref DOI link: https://doi.org/10.1136/rmdopen-2023-003012

Published Online: 2023-06-23

Published Print: 2023-06

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Ghosh, Nilasha https://orcid.org/0000-0002-8799-9309
Reid, Pankti

Aude, Carlos Andres https://orcid.org/0000-0002-1253-1998
Kirschman, Jessica https://orcid.org/0000-0001-7972-8392
Goodman, Susan https://orcid.org/0000-0003-1197-7864
Bykerk, Vivian P https://orcid.org/0000-0002-1219-3845
Lakhanpal, Amit

Rajesh, Diviya

Chan, Karmela K

Robinson, William H

Bass, Anne R https://orcid.org/0000-0002-3225-8351
Funding

Funding for this research was provided by:

HSS Kellen Grant
License Information

License valid from 2023-06-23